Podcasts

Articles

Videos

Certain patient characteristics correlated with a higher rate of fear of cancer recurrence.

Identify, Normalize Fear of Cancer Recurrence

Each month, we take a look back at the most popular Oncology Nursing News® stories. Here are the top 5 stories from February 2021.

Oncology Nursing News Top Stories: February 2021 

This is the third COVID-19 vaccine to be granted emergency use authorization, and is the first single-dose vaccine. 

J&J’s Single-Dose COVID-19 Vaccine Granted EUA

The FDA approved melphalan flufenamide (Pepaxto; melflufen) plus dexamethasone for adults with triple-refractory multiple myeloma.

FDA Approves Melphalan Flufenamide Combo for Triple-Refractory Myeloma

Up to 50% of patients with B-cell malignancies will relapse on CAR T-cell therapy. Investigators are looking in to new ways to overcome that drug resistance.

Overcoming CAR T Resistance in B-Cell Malignancies

The FDA has granted a breakthrough therapy designation to tipifarnib for use in patients with recurrent or metastatic HRAS-mutated head and neck squamous cell carcinoma with variant allele frequency of 20% or higher following progressive disease on platinum-based chemotherapy.

Tipifarnib Gets Breakthrough Therapy Designation for HRAS-Mutated HNSCC

The FDA has approved the PD-L1 IHC 22C3 pharmDx assay, developed by Agilent Technologies Inc, for expanded use in patients with non–small cell lung cancer.

FDA Approves Companion Diagnostic for Cemiplimab in Lung Cancer

While the majority of patients on androgen receptor therapy experienced adverse events, more than a third did not have them resolved. 

Better Treatment Needed for Androgen Receptor Adverse Events

Immunotherapy continues to improve upon the treatment of non-small cell lung cancer, and there are more exciting advancements on the horizon.

Immunotherapy Only Gets Better in NSCLC

The FDA approved single-agent frontline cemiplimab-rwlc (Libtayo) for the treatment of patients with advanced non-small cell lung cancer (NSCLC) with a PD-L1 expression of 50% or greater.

All News